DOI:
10.1055/s-00000017
Experimental and Clinical Endocrinology & Diabetes
LinksClose Window
References
Maiza JC, Vezzosi D, Matta M. et al.
Long-term (up to 18 years) effects on GH/IGF-1 hypersecretion and tumour size of primary somatostatin analogue (SSTa) therapy in patients with GH-secreting pituitary adenoma responsive to SSTa.
Clin Endocrinol 2007; 67: 282-289
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.